Title of article :
Mortality during adjuvant treatment of early breast cancer with cyclophosphamide, methotrexate, and fluorouracil Original Research Article
Author/Authors :
Marco Colleoni، نويسنده , , Karen N Price، نويسنده , , Monica Castiglione-Gertsch، نويسنده , , Richard D Gelber، نويسنده , , Alan S Coates، نويسنده , , Aron Goldirsch and for the International Breast Cancer Study Group، نويسنده ,
Abstract :
Combined chemotherapy for early breast cancer with cyclophosphamide, methotrexate, and fluorouracil has low associated mortality, but related deaths were seen among women aged 65 years or older in International Breast Cancer Study Group trials.